Arrow Mark Colorado Holdings LLC Vertex Pharmaceuticals Inc Transaction History

Arrow Mark Colorado Holdings LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $1.78 Million - $2 Million	-10,688 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $81,894 - $95,517	-562 Reduced 5.0%	10,688 $1.82 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $111,196 - $125,995	-810 Reduced 6.72%	11,250 $1.69 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $1.79 Million - $1.96 Million	12,060	12,060 $1.83 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.